News
Private sector growth boosts India's medical devices market
Private sector growth boosts India's medical devices market
The country could rely more on the sector due to rising healthcare expectations.
Thomson Medical Group sees 1.3% revenue fall in H1
The drop was caused by low patient loads in Singapore, Malaysia.
COVID-19 surge to overwhelm Malaysia's health system: report
ICUs at Hospital Kuala Lumpur and University Malaya Medical Centre have hit full capacity.
Ping An Good Doctor's revenue rose 35.5% to $1.06b in 2020
The company’s average daily consultations jumped 23.9% to 903,000.
111 rolls out mobile healthcare services in Northeast China
Baiyi Doctor Group will provide internet-based diagnosis and treatment.
Thailand's Siriraj Hospital installs telemedicine in mobile stroke unit
A video conferencing system was integrated for doctors to remotely assist stroke patients.
Rising population boosts APAC's over-the-counter drugs market
In countries with high populations, patients rely on neighborhood chemists for medications.
Singapore ranks first in healthcare readiness
It scored a point of 71 in a global index.
China's online healthcare untouched by internet antitrust push
Shares of online healthcare firms soared despite new antitrust laws on internet companies.
Philippines faces risks of limited funding for pandemic response
The country remains vulnerable to another surge in COVID-19 cases.
Japan signs deals for vaccine preorders four times the population
The move was lauded as local vaccines remain in Phase II stage.
Swedish firm acquires Singapore-based dialysis clinic chain ARCA
ARCA operates 18 clinics across Singapore and Malaysia.
Healthcare leaders reveal COVID action plans
They mapped out how the industry should respond to the next pandemic during the Healthcare Asia Virtual Conference.
Thailand to become the medicine hub of Southeast Asia
Japanese drugmakers are interested in establishing their main manufacturing sites in Thailand.
HSBC releases China pharma market outlook for H2
Small cap companies with low valuations could outperform, but leading companies may provide more stable returns.
Sino Biopharma records $1,852m revenue in H1
Earnings per share were 5.2% higher than that of the same period last year.
Lee's Pharma announces H1 results
The group’s revenue is up 3.9% measured QoQ.